Psychiatry and Psychology [F] » Mental Disorders [F03] » Mood Disorders » Depressive Disorder
Description
An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. MeSH
Hierarchy View
Subtype Terms (7)
Depression, Postpartum
30 drugs (28 approved, 2 experimental)
Depressive Disorder, Major
312 drugs (161 approved, 151 experimental)
Depressive Disorder, Treatment-Resistant
70 drugs (48 approved, 22 experimental)
Dysthymic Disorder
20 approved drugs
Premenstrual Dysphoric Disorder
14 drugs (10 approved, 4 experimental)
Seasonal Affective Disorder
4 approved drugs
Vascular Depression
4 approved drugs
Phase 4 Indicated Drugs (18)
Phase 3 Indicated Drugs (14)
Phase 2 Indicated Drugs (21)
Phase 1 Indicated Drugs (7)
Other Experimental Indicated Drugs (10)
Organization Involved with Phase 4 Indications (282)
American Academy of Child Adolescent Psychiatry.
American Foundation for Suicide Prevention
Brain & Behavior Research Foundation
Canadian Research Initiative in Substance Misuse
Capital Clinical Research Associates, LLC
Case Western Reserve University
Centre de recherche Fernand-Seguin, Hôpital Louis-H. Lafontaine
Chinese Academy of Medical Sciences
Chokka Center for Integrative Health
Cognitive Research Corporation
Collaborative Care Initiative, LLC
Corning Hospital, Shenzhen City
Erzurum Regional Training & Research Hospital
Federal University of Rio Grande do Sul
Finnish Foundation for Alcohol Studies
Florida International University
Foundation of Hope, North Carolina
Guizhou Yi Bai Pharmaceutical Co., Ltd.
Hamilton Health Sciences Corporation
Hangzhou Seventh People's Hospital
Health Research Board, Ireland
High Point Regional Health Systems
Hoosier Cancer Research Network
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
Institute for Advanced Medical Research, Alpharetta, GA
Institut National de la Santé Et de la Recherche Médicale, France
Jerusalem Mental Health Center
Lehigh Center for Clinical Research
Medical University of South Carolina
Mental Health Service, Esbjerg
Mental Health Services Svendborg
MercyOne Des Moines Medical Center
Michael J. Gill Mental Health Clinic
Moscow Research Institute of Psychiatry
Nang Kuang Pharmaceutical Co., Ltd.
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
National Center for Research Resources (NCRR)
National Cheng Kung University
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Mental Health (NIMH)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institutes of Health (NIH)
Northumberland, Tyne and Wear NHS Foundation Trust
Ontario Mental Health Foundation
Ontario Neurotrauma Foundation
Oregon Health and Science University
People's Liberation Army of China
Research Foundation for Mental Hygiene, Inc.
Russian Academy of Medical Sciences
Second Military Medical University
Skyland Behavioral Health Associates
South London and Maudsley NHS Foundation Trust
Stanley Medical Research Institute
State University of New York, Buffalo
St Lucas and Andreas Hospital, Amsterdam
St. Luke's-Roosevelt Hospital Center
Taichung Veterans General Hospital
the First Specialized Subject Hospital of Harbin
The Massachusetts Mental Health Center
The Medical Research Network, LLC
The University of Texas, Dallas
Tuscaloosa Research & Education Advancement Corporation (TREAC)
Universidad Autonoma de Ciudad Juarez
University of Alabama, Birmingham
University of British Columbia
University of California, Davis
University of California, Los Angeles
University of California, San Francisco
University of Erlangen-Nuremberg
University of Illinois at Chicago
University of North Carolina at Chapel Hill
University of Southern Denmark
University of Texas, San Antonio
Vita-Salute University of Milano. Italy
WanBangDe Pharmaceutical Group Co.,Ltd.
Organization Involved with Phase 3 Indications (122)
BC Women's Hospital & Health Centre
Beijing First Hospital of integrated Chinese and Western Medicine
Brain and Cognition Discovery Foundation
Canadian Institutes of Health Research (CIHR)
Centre Hospitalier Universitaire de Nīmes
Centro de Investigación Biomédica en Red (CIBER)
China Academy of Chinese Medical Sciences
CIHR Canadian HIV Trials Network
Dow University of Health Sciences
Federal University of Health Science of Porto Alegre
Florida Clinical Research Center, LLC
French National Agency for Research on AIDS and Viral Hepatitis
Institute of Social Security of the Civil Servants of Minas Gerais
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Laureate Institute for Brain Research
Midwest Clinical Research Center, Ohio
Mochida Pharmaceutical Company, Ltd.
National Center of Neurology and Psychiatry, Japan
National Institute for Health Research, United Kingdom
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Drug Abuse (NIDA)
Pakistan Institute of Living and Learning
Pascoe Pharmazeutische Praeparate GmbH
Pharmacology Research Institute
Physicians Research And Education Network
Psychiatric Research Unit, Region Zealand
Psychiatric University Hospital, Zurich
Rawalpindi Medical College, Pakistan
Shijiazhuang Pharma Group (CSPC)
Su Zhou YiHua Biotechnology Co. LTD
Swiss National Science Foundation
The Inflammation Research Foundation
The Physicians' Services Incorporated Foundation
The Royal's Institute of Mental Health Research
The S. Daniel Abraham International Center for Health and Nutrition
Organization Involved with Phase 2 Indications (162)
Alexander Mosely Charitable Trust
American British Cowdray Medical Center
Artemis Institute for Clinical Research
Atlanta Institute of Medicine and Research
Australian National University
Badalona Hospital Germans Trias i Pujol
Chengdu University of Traditional Chinese Medicines
Ciusss de L'Est de l'Île de Montréal
Claghorn-Lesem Research Clinic, Houston TX
Clinical Neuroscience Solutions, Inc.
Collaborative Neuroscience Network
Columbia Northwest Pharmaceuticals
Commonwealth Scientific and Industrial Research Organisation, Australia
CRI-WW Lordes Hospital, Willingboro NJ
Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.
German Federal Ministry of Education and Research
Gottfried Wilhelm Leibniz Universität Hannover
Gulfcoast Clinical Research Center
Hôpital Maisonneuve Rosemont, Montréal, QC, Canada
Hospital de Sant Pau i Santa Tecla de Tarragona
Katholieke Universiteit Leuven
KK Women's and Children's Hospital
Kun Ming KingBio Biotechnology Co. LTD
Leningrad Addiction Treatment & Research Center
Mental Health Services in the Capital Region, Denmark
MSI Methylation Sciences, Inc.
National Institute of General Medical Sciences (NIGMS)
North Star Medical Research LLC
Northwest Clinical Research Center
Oregon Center for Clinical Investigations, Inc
Patient Priority Clinical Sites, LLC
Psychiatric Medicine Associates, L.L.C.
Reckitt Benckiser Pharmaceutical
Rehabilitation Hospital of Indiana
Richard H. Weisler, M.D. and Associates
Section for Affective Disorders; Northern Stockholm Psychiatry
Shanghai University of Traditional Chinese Medicine
State University of New York, Syracuse
The Augustinus Foundation, Denmark.
The Mediterranean Institute for the Advance of Biotechnology and Health Research
The Segal Institute of Clinical Research
Universidade Federal do Rio Grande do Norte
University of California, Irvine
University of California, San Diego
Organization Involved with Phase 1 Indications (40)
Organization Involved with Other Experimental Indications (83)
Abarbanel Mental Health Center
Allama Iqbal Open University Islamabad
American Federation for Aging Research
Bangabandhu Sheikh Mujib Medical University
Center Abarbanel Mental Health
Chhatrapati Sahuji Maharaj Medical University
Collective Healthcare Solutions, LLC
Dalian Seventh People's Hospital
Federal University of Minas Gerais
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Government Medical College, Bhavnagar
Guangdong Provincial Hospital of Traditional Chinese Medicine
Health and Family Welfare Department, Government of Gujarat, India
Instituto de Información e Investigación en Salud Mental A. C.
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Kenya Medical Research Institute
King Edward Medical University
Klinički Bolnički Centar Zagreb
NeuroCure Clinical Research Center
Neurological Associates of West Los Angeles
Nicolaus Copernicus University
Shanghai Ankang Pharmaceutical Co.,LTD
Shanghai Wu Mengchao Medical Foundation
Sir T. General Hospital and Government Medical College
Technical University of Dresden
The Depressive and Bipolar Disorder Alternative Treatment Foundation
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
